RNAi therapeutics: an update on delivery.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Current opinion in molecular therapeutics (Print)

• Publication date

  2008-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 18386228
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Delivering the future.

  2009cited by this paper
• Development of therapeutic siRNAs for pachyonychia congenita.

  2008cited by this paper
• Single-nucleotide-specific siRNA targeting in a dominant-negative skin model.

  2008cited by this paper
• Inhibition of tumor necrosis factor alpha secretion in rat Kupffer cells by siRNA: in vivo efficacy of siRNA-liposomes.

  2008cited by this paper
• Systemic Leukocyte-Directed siRNA Delivery Revealing Cyclin D1 as an Anti-Inflammatory Target

  2008cited by this paper
• Selective gene silencing in activated leukocytes by targeting siRNAs to the integrin lymphocyte function-associated antigen-1

  2007cited by this paper
• Stable reduction of CCR5 by RNAi through hematopoietic stem cell transplant in non-human primates

  2007cited by this paper
• Small RNAs: Delivering the future

  2007cited by this paper
• Targeted inhibition of HBV gene expression by single‐chain antibody mediated small interfering RNA delivery

  2007cited by this paper
• Effectiveness of siRNA uptake in target tissues by various delivery methods.

  2007cited by this paper
• Strategies for silencing human disease using RNA interference

  2007cited by this paper
• Cequent Pharmaceuticals, Inc.: the biological pitcher for RNAi therapeutics.

  2007cited by this paper
• Nonviral delivery of synthetic siRNAs in vivo.

  2007cited by this paper
• Dynamic PolyConjugates for targeted in vivo delivery of siRNA to hepatocytes

  2007cited by this paper
• Gene therapy progress and prospects: Hydrodynamic gene delivery

  2007cited by this paper
• Intravenous siRNA of Brain Cancer with Receptor Targeting and Avidin–Biotin Technology

  2007cited by this paper
• Local knockdown of genes in the brain using small interfering RNA: a phenotypic comparison with knockout animals.

  2007cited by this paper
• Interfering with disease: a progress report on siRNA-based therapeutics

  2007cited by this paper
• Genetic therapies against HIV

  2007cited by this paper
• Effective RNAi-mediated gene silencing without interruption of the endogenous microRNA pathway

  2007cited by this paper
• Mechanisms and optimization of in vivo delivery of lipophilic siRNAs

  2007cited by this paper
• Intratumoral delivery and suppression of prostate tumor growth by attenuated Salmonella enterica serovar typhimurium carrying plasmid-based small interfering RNAs.

  2007cited by this paper
• RNAi therapeutics: a potential new class of pharmaceutical drugs

  2006cited by this paper
• RNA interference in the mouse vascular endothelium by systemic administration of siRNA-lipoplexes for cancer therapy

  2006cited by this paper
• An siRNA-based microbicide protects mice from lethal herpes simplex virus 2 infection

  2006cited by this paper
• RNAi-mediated gene silencing in non-human primates

  2006cited by this paper
• Innate immune recognition of viral infection.

  2006cited by this paper
• Cell type–specific delivery of siRNAs with aptamer-siRNA chimeras

  2006cited by this paper
• Reconstituted influenza virus envelopes as an efficient carrier system for cellular delivery of small-interfering RNAs

  2006cited by this paper
• Inhibition of choroidal neovascularization by adenovirus-mediated delivery of short hairpin RNAs targeting VEGF as a potential therapy for AMD.

  2006cited by this paper
• A novel siRNA-lipoplex technology for RNA interference in the mouse vascular endothelium

  2006cited by this paper
• Engineering mucosal RNA interference in vivo.

  2006cited by this paper
• The silent treatment: siRNAs as small molecule drugs

  2006cited by this paper
• Fatality in mice due to oversaturation of cellular microRNA/short hairpin RNA pathways

  2006cited by this paper
• Short hairpin RNA–expressing bacteria elicit RNA interference in mammals

  2006cited by this paper
• Induction of the interferon response by siRNA is cell type- and duplex length-dependent.

  2006cited by this paper
• Suppression of ocular neovascularization with siRNA targeting VEGF receptor 1

  2006cited by this paper
• Reconstituted influenza virus envelopes as an efficient carrier system for cellular delivery of small-interfering RNAs

  2006cited by this paper
• Delivery of RNA Interference

  2006cited by this paper
• Potent and persistent in vivo anti-HBV activity of chemically modified siRNAs

  2005cited by this paper
• Using siRNA in prophylactic and therapeutic regimens against SARS coronavirus in Rhesus macaque

  2005cited by this paper
• First clinical data on RNAi.

  2005cited by this paper
• Inhibition of respiratory viruses by nasally administered siRNA

  2005cited by this paper
• Activity of stabilized short interfering RNA in a mouse model of hepatitis B virus replication

  2005cited by this paper
• An efficient intrathecal delivery of small interfering RNA to the spinal cord and peripheral neurons

  2005cited by this paper
• Design of a genome-wide siRNA library using an artificial neural network

  2005cited by this paper
• Synthetic dsRNA Dicer substrates enhance RNAi potency and efficacy

  2005cited by this paper
• Antibody mediated in vivo delivery of small interfering RNAs via cell-surface receptors

  2005cited by this paper
• Sequence-dependent stimulation of the mammalian innate immune response by synthetic siRNA

  2005cited by this paper
• Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs

  2004cited by this paper
• Neurochemical and behavioral consequences of widespread gene knockdown in the adult mouse brain by using nonviral RNA interference.

  2004cited by this paper
• Pegaptanib for neovascular age-related macular degeneration.

  2004cited by this paper
• INTRAVITREAL INJECTION OF VASCULAR ENDOTHELIAL GROWTH FACTOR SMALL INTERFERING RNA INHIBITS GROWTH AND LEAKAGE IN A NONHUMAN PRIMATE, LASER-INDUCED MODEL OF CHOROIDAL NEOVASCULARIZATION

  2004cited by this paper
• Sequence, Chemical, and Structural Variation of Small Interfering RNAs and Short Hairpin RNAs and the Effect on Mammalian Gene Silencing

  2003cited by this paper
• In vivo knockdown of gene expression in brain cancer with intravenous RNAi in adult rats

  2003cited by this paper
• A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency.

  2003cited by this paper
• Small interfering RNA (siRNA) targeting VEGF effectively inhibits ocular neovascularization in a mouse model.

  2003cited by this paper
• Bacteria as tumour-targeting vectors.

  2003cited by this paper
• Short hairpin RNAs (shRNAs) induce sequence-specific silencing in mammalian cells.

  2002cited by this paper
• Stable suppression of gene expression by RNAi in mammalian cells

  2002cited by this paper
• Fomivirsen for the treatment of cytomegalovirus retinitis.

  2002cited by this paper
• RNA interference by expression of short-interfering RNAs and hairpin RNAs in mammalian cells

  2002cited by this paper
• Efficient delivery of siRNA for inhibition of gene expression in postnatal mice

  2002cited by this paper
• Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells

  2001cited by this paper
• RNA interference is mediated by 21- and 22-nucleotide RNAs.

  2001cited by this paper
• Noninvasive gene targeting to the brain.

  2000cited by this paper
• Phase 2 Clinical Trial of AttenuatedSalmonella enterica Serovar Typhi Oral Live Vector Vaccine CVD 908-htrA in U.S. Volunteers

  2000cited by this paper
• Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans

  1998cited by this paper
• Functional gene transfer from intracellular bacteria to mammalian cells

  1998cited by this paper
• Tumor-targeted Salmonella as a novel anticancer vector.

  1997cited by this paper
• Identification of invasin: a protein that allows enteric bacteria to penetrate cultured mammalian cells.

  1987cited by this paper
• Systemic Leukocyte-Directed siRNA Delivery Revealing Cyclin D 1 as an Anti-Inflammatory Target

  year unknowncited by this paper

• Immunoinformatic and molecular docking approaches: siRNA prediction to silence cell surface binding protein of monkeypox virus

  2024cites this paper
• From sequences to therapeutics: Using machine learning to predict chemically modified siRNA activity.

  2024cites this paper
• From sequences to therapeutics: Machine learning predicts chemically modified siRNA Activity

  2023cites this paper
• Novel molecular approaches to combat vectors and vector-borne viruses: Special focus on RNA interference (RNAi) mechanisms.

  2022cites this paper
• Rationale and Application of PEGylated Lipid-Based System for Advanced Target Delivery of siRNA

  2021cites this paper
• Therapeutic Potential of microRNA Against Th2-associated Immune Disorders.

  2021cites this paper
• Recent developments in targeting genes and pathways by RNAi‐based approaches in colorectal cancer

  2020cites this paper
• miRNA signatures in childhood sarcomas and their clinical implications

  2019cites this paper
• MicroRNA dysregulation interplay with childhood abdominal tumors

  2019cites this paper
• Aberrantly expressed microRNAs and their implications in childhood central nervous system tumors

  2019cites this paper
• The potential of siRNA based drug delivery in respiratory disorders: Recent advances and progress

  2019cites this paper
• Allele-specific silencing as treatment for gene duplication disorders: proof-of-principle in autosomal dominant leukodystrophy.

  2019cites this paper
• Nucleic‐acid based gene therapy approaches for sepsis

  2018cites this paper
• Expression profiles and prognostic value of miRNAs in retinoblastoma

  2018cites this paper
• Adeno-Associated Virus-Mediated RNAi against Mutant Alleles Attenuates Abnormal Calvarial Phenotypes in an Apert Syndrome Mouse Model

  2018cites this paper
• Molecular Mechanisms and Biological Functions of siRNA

  2017cites this paper
• Validation of a feeding strategy to deliver bacterially expressed dsRNA to marine amoeba from the genus Neoparamoeba

  2017cites this paper
• Application of nanotechnology for the development of microbicides

  2017cites this paper
• Update on the clinical utility of an RNA interference-based treatment: focus on Patisiran

  2017cites this paper
• Control of Gene Expression by RNAi: A Revolution in Functional Genomics

  2017cites this paper
• Different chemical strategies to aminate oxidised multi-walled carbon nanotubes for siRNA complexation and delivery.

  2016cites this paper
• Properties of Native High‐Density Lipoproteins Inspire Synthesis of Actively Targeted In Vivo siRNA Delivery Vehicles

  2016cites this paper
• Hyaluronic-acid based nanocarriers for RNAi therapy of advanced sepsis

  2015cites this paper
• A 28-day oral toxicity evaluation of small interfering RNAs and a long double-stranded RNA targeting vacuolar ATPase in mice.

  2015cites this paper
• MicroRNAs and Targeted Therapies in Non-small Cell Lung Cancer: Minireview.

  2015cites this paper
• Surface modification of tri-calcium phosphate nanoparticles by DOPE and/or anti-E6 antibody to enhance uptake of antisense of E6 mRNA.

  2015cites this paper
• RNA interference as an alternative preventive measure for avian influenza in poultry

  2015cites this paper
• Killing Effect of Ad 5 / F 35-APE 1 siRNA Recombinant Adenovirus in Combination with Hematoporphrphyrin Derivative-Mediated Photodynamic Therapy on Human Nonsmall Cell Lung Cancer

  2015cites this paper
• Silençage du gène ApoB codant pour l’apolipoprotéine B responsable de l’athérosclérose, in vitro et in vivo, à l’aide des nanoparticules chitosane/siARN-ApoB

  2014cites this paper
• Novel antiviral strategies for feline coronavirus and feline calicivirus

  2014cites this paper
• High-density lipoproteins for the systemic delivery of short interfering RNA

  2014cites this paper
• RNA Interference and Its Applications

  2014cites this paper
• Systemic delivery of phosphorylated nucleoside analogues and siRNA via LCP nanoparticles for cancer therapy

  2013cites this paper
• Bioinspired peptides as versatile nucleic acid delivery platforms.

  2013cites this paper
• RNA interference targeting E637K mutation rescues hERG channel currents and restores its kinetic properties.

  2013cites this paper
• Safety assessment of food and feed from biotechnology-derived crops employing RNA-mediated gene regulation to achieve desired traits: a scientific review.

  2013cites this paper
• Potential function of miRNAs in herpetic stromal keratitis.

  2013cites this paper
• Delivery Systems and Local Administration Routes for Therapeutic siRNA

  2013cites this paper
• Cytoplasmic RNA viruses as potential vehicles for the delivery of therapeutic small RNAs

  2013cites this paper
• An Aptamer–siRNA Chimera Silences the Eukaryotic Elongation Factor 2 Gene and Induces Apoptosis in Cancers Expressing αvβ3 Integrin

  2013cites this paper
• RNA Interference for Oncology: Clinical Prospects Beyond the Hype

  2013cites this paper
• Is Suppression of Apoptosis a New Therapeutic Target in Sepsis?

  2013cites this paper
• RNAi as Antiviral Therapy: The HIV-1 Case

  2013cites this paper
• Investigating Novel Block Copolypeptide Vesicles for the Enhanced Delivery of Therapeutics

  2013cites this paper
• Allele-specific siRNA silencing for the common keratin 12 founder mutation in Meesmann epithelial corneal dystrophy.

  2013cites this paper
• Ameloblastin in Hertwig’s Epithelial Root Sheath Regulates Tooth Root Formation and Development

  2013cites this paper
• Ewing's Sarcoma: Development of RNA Interference-Based Therapy for Advanced Disease

  2012cites this paper
• Killing Effect of Ad5/F35-APE1 siRNA Recombinant Adenovirus in Combination with Hematoporphrphyrin Derivative-Mediated Photodynamic Therapy on Human Nonsmall Cell Lung Cancer

  2012cites this paper
• SiRNA Inhibits Replication of Langat Virus, a Member of the Tick-Borne Encephalitis Virus Complex in Organotypic Rat Brain Slices

  2012cites this paper
• In vivo delivery aspects of miRNA, shRNA and siRNA.

  2012cites this paper
• Self-assembled polypeptide and polypeptide hybrid vesicles: from synthesis to application.

  2012cites this paper
• Identification of critical points in colloidal delivery systems for intravenous administration and intracellular delivery of nucleic acids as therapeutic agents

  2012cites this paper
• RNA interference: A futuristic tool and its therapeutic applications.

  2012cites this paper
• Synthesis and Preliminary Investigations of the siRNA Delivery Potential of Novel, Single-Chain Rigid Cationic Carotenoid Lipids

  2012cites this paper
• Engineering Biomaterials for Regenerative Medicine: Novel Technologies for Clinical Applications

  2012cites this paper
• Nonviral Gene Delivery for Applications in Regenerative Medicine

  2012cites this paper
• Specific delivery of therapeutic agents against cancers

  2012influential citation
• Intranasal delivery of siRNA to the olfactory bulbs of mice via the olfactory nerve pathway.

  2012cites this paper
• Find, Fight, Follow: Ultrasound triggered image-guided drug delivery

  2012cites this paper
• Surface Modulation of Nanoparticles

  2012cites this paper
• Development of quantitative molecular clinical end points for siRNA clinical trials.

  2011cites this paper
• See, reach, treat: ultrasound-triggered image-guided drug delivery.

  2011cites this paper
• UvA-DARE ( Digital Academic Repository ) Silencing of HIV-1 cofactors Eekels

  2011cites this paper
• Downregulation of uPAR inhibits migration, invasion, proliferation, FAK/PI3K/Akt signaling and induces senescence in papillary thyroid carcinoma cells

  2011cites this paper
• RNAi knockdown of PIK3CA preferentially inhibits invasion of mutant PIK3CA cells.

  2011cites this paper
• The Use of Nonhuman Animals in Biomedical Research

  2011cites this paper
• Characterization of small interfering RNA by non-denaturing ion-pair reversed-phase liquid chromatography.

  2011cites this paper
• Characterization of side reactions during the annealing of small interfering RNAs.

  2011cites this paper
• DNA-triggered synthesis and bioactivity of proapoptotic peptides.

  2011cites this paper
• Herpesvirus saimiri‐based endothelin‐converting enzyme‐1 shRNA expression decreases prostate cancer cell invasion and migration

  2011cites this paper
• Toward a durable treatment of HIV-1 infection using RNA interference.

  2011cites this paper
• Antibody targeted siRNA delivery.

  2011cites this paper
• Personalized Cancer Approach: Using RNA Interference Technology

  2011cites this paper
• Purification of Small Interfering RNA Using Nondenaturing Anion-Exchange Chromatography

  2011cites this paper
• RNA interference for improving the outcome of islet transplantation and polymeric micelle-based nanomedicine for cancer therapy

  2011cites this paper
• Latest Therapeutic Approaches Based on Cancer Stem Cells

  2011cites this paper
• Investigating the Effects of Silencing EphA2 in Metastatic Breast Cancer Cells

  2011influential citation
• RNA Drug Delivery Approaches

  2011cites this paper
• Novel siRNA lipoplexes : their targeted and untargeted delivery to mammalian cells in culture.

  2011influential citation
• DNA‐gesteuerte Synthese und Bioaktivität proapoptotischer Peptide

  2011cites this paper
• Calcium Phosphate and Calcium Phosphosilicate Mediated Drug Delivery and Imaging

  2011cites this paper
• RNA interference for improving the outcome of islet transplantation.

  2011cites this paper
• Functionalized carbon nanotubes for probing and modulating molecular functions.

  2010cites this paper
• Advantages of bioluminescence imaging to follow siRNA or chemotherapeutic treatments in osteosarcoma preclinical models

  2010cites this paper
• RNAi Treatment of HIV-1 Infection

  2010cites this paper
• Future prospect of RNA interference for cancer therapies.

  2010cites this paper
• p53‐Associated Parkin‐like cytoplasmic protein (Parc) short‐interfering RNA (siRNA) alters p53 location and biology of Peyronie’s disease fibroblasts

  2010cites this paper
• Inhibition of the microRNA pathway in zebrafish by siRNA.

  2010cites this paper
• First-in-human mutation-targeted siRNA phase Ib trial of an inherited skin disorder.

  2010cites this paper
• RNAi in Malignant Brain Tumors: Relevance to Molecular and Translational Research

  2010cites this paper
• Pseudovirions as Vehicles for the Delivery of siRNA

  2010cites this paper
• Reversed-phase high-performance liquid chromatography method for simultaneous analysis of two liposome-formulated short interfering RNA duplexes.

  2010cites this paper
• Engineered E. coli as vehicles for targeted therapeutics.

  2010cites this paper
• New Core-Shell Nanoparticules for the Intravenous Delivery of siRNA to Experimental Thyroid Papillary Carcinoma

  2010cites this paper
• Insights into sepsis therapeutic design based on the apoptotic death pathway.

  2010cites this paper
• Convenient targeting of stealth siRNA-lipoplexes to cells with chelator lipid-anchored molecules.

  2009cites this paper
• Oncomirs: from tumor biology to molecularly targeted anticancer strategies.

  2009cites this paper
• Antitumor effect of RNA interference on non-small-cell lung cancer in vivo

  2009cites this paper
• siRNAs: their potential as therapeutic agents--Part II. Methods of delivery.

  2009cites this paper
• siRNA delivery using peptide transduction domains.

  2009cites this paper